Skip to content

Mazdutide vs Semaglutide

Updated 6 sources

Key differences

  1. 1Semaglutide is GLP-1 only. Mazdutide adds glucagon activity aimed at energy use and liver fat.
  2. 2Innovent's DREAMS-3 phase 3 trial compares them head to head in Chinese adults with type 2 diabetes and obesity.

Side by side

Facts from each record, in the same words as their own pages.
Mazdutide and Semaglutide side by side
MazdutideSemaglutide
Category
  • GLP-1, Weight loss
  • GLP-1, Weight loss
Evidence
  • Strong human trials
  • Strong human trials
FDA status
  • In clinical trialsRegulatory
  • FDA approved as Ozempic +2Regulatory
WADA
  • Not prohibited
  • Not prohibited
Half-life
  • 6.3 to 16.8 days after the first dose in a phase 1b trial in Chinese adults; peak levels at a median of 72 hours.Clinical study
  • About 1 week. It is still present 5 to 7 weeks after the last dose.Regulatory
Routes
  • Subcutaneous injection
  • Subcutaneous injection, Oral
Forms
  • Prefilled pen, Vial (powder)
Not reported
Reported doses
  • 1 to 16 mg (subcutaneous injection)
  • 0.125 to 7.2 mg (subcutaneous injection)
  • 1.5 to 25 mg (oral)
  • 300 to 1,000 mcg (subcutaneous injection)
Most cited frequency
  • Once weekly: 2 mg for 4 weeks, 4 mg for 4 weeks, then 4 or 6 mg to maintain
  • Once weekly; 4 weeks per step, then hold at 2.4 mg
Vial sizes
  • 5 mg, 10 mg, 15 mg, 20 mgCompetitor guide
  • 5 mg, 10 mg, 20 mg, 30 mgVendor guide
Mixed vial keeps
  • Keep the mixed vial in the fridge at 2 to 8 C and never freeze it.Competitor guide
  • Keep the mixed vial in the fridge and use it within about 28 days; one guide says 30.Competitor guide
Protocols on file
  • 13
  • 12

Doses shown are what sources report, labelled by origin. Not medical advice.

Read each in full

Sources

6 sources, each checked by date. Record updated Oct 24, 2026. Numbers are restated in our own words and labelled by where they came from.

Regulatory4

  1. Ozempic Prescribing Information (rev. 01/2025)FDA · checked Oct 23, 2026
  2. Wegovy injection and tablets label (SPL v19, Jun 30 2026)DailyMed · checked Oct 24, 2026
  3. Mazdutide: First ApprovalDrugs (PubMed record), via a reference work · checked Oct 24, 2026
  4. Innovent Announces Mazdutide Received Approval from China's NMPA for Glycemic Control in Adults with Type 2 DiabetesInnovent Biologics (via BioSpace), via a news report · checked Oct 24, 2026